Form 8-K - Current report:
SEC Accession No. 0001213900-13-005292
Filing Date
2013-09-20
Accepted
2013-09-20 16:09:08
Documents
1
Period of Report
2013-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091613_actiniumphar.htm 8-K 46695
  Complete submission text file 0001213900-13-005292.txt   47937
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 131107994
SIC: 6770 Blank Checks